EU provisionally approves framework for new genomic technique plants from 2028

EU member states and the European Parliament have provisionally agreed a new regulatory framework for plants produced by new genomic techniques (NGTs). The deal creates two pathways to market — a lighter verification route for certain NGT1 plants and full GMO rules for NGT2 — while preserving the possibility to patent NGT plants under specified transparency requirements. Read the full article for implications on market access, patenting obligations and the outlook for NGT innovation in Europe.

Click here to read the full article